Engineered 3D environments to elucidate the effect of environmental parameters on drug response in cancer.

Traditional in vitro models used for the development of anti-cancer drugs are based on the monolayer culture of cells, which has a limited predictivity of in vivo efficacy. A number of cell culture platforms have been developed in recent years to improve predictivity and further to elucidate the mechanisms governing the differing responses observed in vitro versus in vivo. One detrimental aspect of current in vitro models is their inability to decouple the effect of different extrinsic factors on the responsiveness of the cells to drug treatment. Here, we have used an engineered poly(dimethylsiloxane) (PDMS) microwell array as a reductionist approach to study the effect of environmental parameters, independently of each other. It is observed for MCF-7 breast cancer cells, that culture within the three-dimensional (3D) environment of the microwells alone had an effect on the response to Taxol and results in a reduction of cell death in comparison to cells cultured on flat substrates. Additionally the microwells allowed the response of single versus multicell clusters to be differentiated. It was found that the formation of cell-cell contacts alters the drug response, depending on the type of adhesive protein present. Thus, with this microwell platform it is revealed that the presence of cell-cell contacts in addition to the dimensionality and the matrix composition of the environment are important mediators of altered drug responses. In conclusion the microwell array can not only serve as a platform to reveal which parameters of the extracellular environment affect drug response but further the interdependence of these parameters.

[1]  M. Textor,et al.  Dimensionality Controls Cytoskeleton Assembly and Metabolism of Fibroblast Cells in Response to Rigidity and Shape , 2010, PloS one.

[2]  K O Greulich,et al.  UVA-induced apoptosis studied by the new apo/necro-Comet-assay which distinguishes viable, apoptotic and necrotic cells. , 2006, Mutagenesis.

[3]  D. Henley,et al.  Paclitaxel induced apoptosis in breast cancer cells requires cell cycle transit but not Cdc2 activity , 2006, Cancer Chemotherapy and Pharmacology.

[4]  C. Mettlin,et al.  Global breast cancer mortality statistics , 1999, CA: a cancer journal for clinicians.

[5]  G. Adler,et al.  Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. , 2006, Cancer research.

[6]  Rolf Larsson,et al.  Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828. , 2004, Molecular cancer therapeutics.

[7]  Alok R Ray,et al.  Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. , 2005, Biomaterials.

[8]  E. Cukierman,et al.  Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins , 2009, BMC Cancer.

[9]  Dietmar W Hutmacher,et al.  The challenge to measure cell proliferation in two and three dimensions. , 2005, Tissue engineering.

[10]  J. Heino The collagen receptor integrins have distinct ligand recognition and signaling functions. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[11]  Juergen Friedrich,et al.  Experimental anti-tumor therapy in 3-D: Spheroids – old hat or new challenge? , 2007, International journal of radiation biology.

[12]  P. Janmey,et al.  Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. , 2005, Cell motility and the cytoskeleton.

[13]  E. Kubista,et al.  Extracellular matrix proteins influence phenotype and cytokine expression in human breast cancer cell lines. , 2002, European cytokine network.

[14]  J. Bryant,et al.  Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Christopher S. Chen,et al.  Cellular and multicellular form and function. , 2007, Advanced drug delivery reviews.

[16]  J. van den Dolder,et al.  The behavior of osteoblast-like cells on various substrates with functional blocking of integrin-β1 and integrin-β3 , 2007, Journal of materials science. Materials in medicine.

[17]  W. Dalton,et al.  Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death , 2003, Oncogene.

[18]  Kenneth M. Yamada,et al.  Cell migration in 3D matrix. , 2005, Current opinion in cell biology.

[19]  L. Kam,et al.  Rigidity-dependent cross talk between integrin and cadherin signaling. , 2009, Biophysical journal.

[20]  E. Golemis,et al.  Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. , 2008, Matrix biology : journal of the International Society for Matrix Biology.

[21]  Dan H. Moore,et al.  Increased β1 Integrin Is Associated with Decreased Survival in Invasive Breast Cancer , 2007 .

[22]  F. Aoudjit,et al.  Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells , 2001, Oncogene.

[23]  S. Sahoo,et al.  3-D tumor model for in vitro evaluation of anticancer drugs. , 2008, Molecular pharmaceutics.

[24]  Tobias Schmelzle,et al.  Engineering tumors with 3D scaffolds , 2007, Nature Methods.

[25]  Jie Liu,et al.  Expression of kidney injury molecule-1 (Kim-1) in relation to necrosis and apoptosis during the early stages of Cd-induced proximal tubule injury. , 2009, Toxicology and applied pharmacology.

[26]  A. Ivascu,et al.  Rapid Generation of Single-Tumor Spheroids for High-Throughput Cell Function and Toxicity Analysis , 2006, Journal of biomolecular screening.

[27]  Robert S. Kerbel,et al.  E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1 , 1998, The Journal of cell biology.

[28]  M. Textor,et al.  single cells{ , 2007 .

[29]  Viola Vogel,et al.  Crosslinking of cell-derived 3D scaffolds up-regulates the stretching and unfolding of new extracellular matrix assembled by reseeded cells. , 2009, Integrative biology : quantitative biosciences from nano to macro.

[30]  Genee Y. Lee,et al.  The morphologies of breast cancer cell lines in three‐dimensional assays correlate with their profiles of gene expression , 2007, Molecular oncology.

[31]  T. Aas,et al.  Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy. , 2003, European journal of cancer.

[32]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[33]  G. Hortobagyi,et al.  Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. , 1991, Journal of the National Cancer Institute.

[34]  Christopher S. Chen,et al.  Engineering cellular microenvironments to improve cell-based drug testing. , 2002, Drug discovery today.

[35]  A. Charchanti,et al.  Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression. , 2002, European journal of cancer.

[36]  Robert A. Gatenby,et al.  Environment-mediated drug resistance: a major contributor to minimal residual disease , 2009, Nature Reviews Cancer.

[37]  G. Hortobagyi Opportunities and challenges in the development of targeted therapies. , 2004, Seminars in oncology.

[38]  A. Ivascu,et al.  Diversity of cell-mediated adhesions in breast cancer spheroids. , 2007, International journal of oncology.

[39]  R. Kerbel,et al.  Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro. , 2004, Molecular cancer therapeutics.

[40]  K. Neoh,et al.  Human bone marrow-derived mesenchymal stem cells and osteoblast differentiation on titanium with surface-grafted chitosan and immobilized bone morphogenetic protein-2. , 2009, Journal of materials science. Materials in medicine.

[41]  James P. Freyer,et al.  The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model , 2004, Journal of biomolecular screening.